• Wed, December 4, 2024

by: Thomas Matters

Billionaire Ken Griffin Just Increased Citadel's Position in This Unstoppable ETF by 277%

Ken Griffin's Citadel Advisors just increased its stake in a very successful S&P 500-themed ETF.

by: Thomas Matters

Top AI Stocks For 2024: Investment Tips From An Expert

by: Thomas Matters

Intel Axes CEO Pat Gelsinger: Is It Time to Buy the Struggling Chip Stock?

Gelsinger spent most of his career at Intel, rising to chief technology officer before leaving to run VMWare in 2012 and then returning as CEO in 2021. He was generally well respected by Wall Street and industry insiders, but on his watch, the stock underperformed the market as Intel lost ground in the AI race to Nvidia.

by: Thomas Matters

Traders Focus On Central Bank Action in India After Poor GDP Growth

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at:

by: Thomas Matters

Top oil and gas stocks to buy now in Australia

Analysts believe that these stocks could energise portfolios with some big returns. The post Top oil and gas stocks to buy now in Australia appeared first on The Motley Fool Australia.

by: Thomas Matters

Brokers Suggest Investing in MakeMyTrip (MMYT): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price,

by: Thomas Matters

SIMON BROWN: Yes, buy top stocks for the bottom drawer

When I was learning about markets in the 1980s, was something that was often mentioned was the idea of bottom-drawer shares.

by: Thomas Matters

2 Dividend-Paying Stocks Suze Orman Says To Consider Investing In

When it comes to the markets, the results of the recent election have caused jubilation in some corners of the country and fear in others. In a post-election episode of her "Women &

by: Thomas Matters

10 Of The Best Investment Apps For Android Users (According To User Rating)

It's easier than ever to engage with the stock and bond markets via your Android phone, and these apps have made the experience enjoyable, to boot.

by: Thomas Matters

Understanding The Difference Between Value VS. Market Cap Weighted

When it comes to investing, two common methods of portfolio construction and index strategies are value-weighted and market-cap weighted approaches. Both of these strategies offer unique ways of measuring the importance of individual assets within a portfolio or index,

by: Thomas Matters

Why Janux Therapeutics Crushed the Market Today

  • Thu, December 5, 2024

by: Motley Fool Australia

1 Australian energy stock to buy confidently and 1 to avoid for now

These two Australian energy stocks sit at opposite ends of the pole for investors to consider. Let's take a look.

by: The Daily Telegraph

In 1964, we recommended five shares - we'd buy these again today

Questor celebrates its 60th anniversary this week, offering a good opportunity to draw parallels between 1964 and today...

by: Seeking Alpha

The Cost Of Euphoria: Why Palantir's Rally Could Be A Mirage

Palantir's impressive quarterly results and growth rates are overshadowed by the unrealistic expectations for future FCF growth. Read why PLTR stock is a Sell.

by: Thomas Matters

Harbor Large Cap Value Fund Q3 2024 Commentary

During the third quarter, the Harbor Large Cap Value Fund returned 6.29%, underperforming its benchmark, the Russell 1000 Value Index, which returned 9.43%.

by: Thomas Matters

Nvidia Stock Is Up 187% in 2024, but Here's Another Super Semiconductor Stock to Buy in 2025, According to Wall Street

by: Thomas Matters

Five Below stock surges on raised guidance, new CEO

Five Below Inc (NASDAQ:FIVE) shares jumped 8% after the discount retailer reported better-than-expected third quarter results and raised its full-year outlook. The company also announced the appointment of a new CEO.

by: The Motley Fool

Why Intuitive Machines Stock Just Crashed 14%

According to data from S&P Global Market Intelligence, Intuitive burned through more than $75 million in free cash flow last year, and cash burn has increased this year. Although Intuitive has won several lucrative contracts from NASA, Wall Street analysts don't expect it to turn free-cash-flow-positive and begin earning profits until 2026.

by: The Motley Fool

Why C3.ai Stock Soared 51% in November

C3.ai stock rose 7% on Nov. 5 and jumped another 5% on Nov. 6 in response to the U.S. election results.

by: Thomas Matters

Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?

by: Thomas Matters

Schroders financial advisers predict cash savings exodus

Poll of financial advisers suggests optimism for the equity market and a move away from cash, but that growth could come at the cost of higher volatility

by: Thomas Matters

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years. And although Pfizer's revenue is growing again,

by: Thomas Matters

Goldman Sachs Says These 2 Steel Stocks Are a 'Buy' Amid Improving Fundamentals

The art of stock investing lies in identifying the right equities to buy. One effective approach is focusing on core economic sectors - industries that sustain the foundations of modern life. Among these,

by: Thomas Matters

Remembering Art Cashin's most valuable stock market lessons - and the stories behind them

by: Thomas Matters

ANZ, Commonwealth Bank, NAB and Westpac have had a monster 2024. Can it continue?

Commonwealth Bank of Australia (ASX: CBA), National Australia Bank (ASX: NAB), and Westpac Banking Corporation (ASX: WBC) are a cornerstone of many Australian investors' portfolios. Most ASX bank stocks are sporting year-to-date returns in excess of 10%,

by: Thomas Matters

Bitcoin price hits $100,000 - should you buy into the crypto boom?

Crossing the $100,000 threshold is a landmark moment for the Bitcoin price, but is this high-risk asset a fool's gold?

by: Thomas Matters

Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?

The S&P 500 has hit record levels this year and many stocks have generated fantastic returns for investors. But there's been no shortage of struggling investments, either. Many companies that have been finding it difficult to grow and that may not have any near-term catalysts on the horizon have seen their shares fall sharply this year.

by: Thomas Matters

Fed Leans Toward A December Interest Rate Cut

The Federal Open Market Committee is most likely to cut interest rates again to 4.25% to 4.5% on December 18 according to fixed income markets.

by: Thomas Matters

Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today

by: Thomas Matters

I would listen to Warren Buffett's advice and buy undervalued ASX shares today

It's never a bad idea to follow in the footsteps of the Oracle of Omaha. The post I would listen to Warren Buffett's advice and buy undervalued ASX shares today appeared first on The Motley Fool Australia.

by: Thomas Matters

3 Top Buffett Stocks to Buy and Hold for the Long Haul

Buffett just bought more shares of Heico, a low-cost supplier of aircraft parts with a long record of outperformance. Berkshire also increased its stake in satellite radio provider Sirius XM. It now owns nearly one-third of the company.

by: Thomas Matters

Salesforce price target raised to $425 from $415 at Barclays

Barclays raised the firm's price target on Salesforce (CRM) to $425 from $415 and keeps an Overweight rating on the shares post the Q3 report. The

by: Thomas Matters

Stellantis Is Headed for Disaster

Stellantis ( STLA 1.76%) seemed to be on the path to recovery after the worst of the pandemic, but now that the market has gotten back to a more normalized supply-and-demand environment, the company's sales have dropped. In this video, Travis Hoium shows why strategic difficulties are at the core of Stellantis' problems.

by: Thomas Matters

Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.

Three stocks that I think could be good growth stocks if you have $5,000 to invest today are Pfizer ( PFE -1.29%), ExxonMobil ( XOM -2.88%), and Carnival Corp. ( CCL 2.57%). Here's why these can be ideal options for growth investors, particularly if you're looking for good value buys, as well.

by: Thomas Matters

The CRA is Watching TFSA Holders: Here Are Some Red Flags to Avoid

There are some bad red flags that many investors may be overlooking, but fear not! Here's how to side step them, and invest.

by: Thomas Matters

The UK tech stocks worth owning

by: Thomas Matters

Google's new gen AI video model Veo available on Vertex AI private preview

by: Thomas Matters

3 ASX 300 shares with ex-dividend dates before the end of 2024

Do you want the latest payment from these shares that are set to trade ex-dividend? The post 3 ASX 300 shares with ex-dividend dates before the end of 2024 appeared first on The Motley Fool Australia.

by: Thomas Matters

2 high-yield ASX dividend shares for Australian retirees

Analysts are tipping these shares as buys and expect big things from them. The post 2 high-yield ASX dividend shares for Australian retirees appeared first on The Motley Fool Australia.

by: Thomas Matters

5 things to watch on the ASX 200 on Thursday

A better session is expected for Aussie investors today. Here's what you need to know. The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

by: Thomas Matters

Dow Jones Futures: Bitcoin Hits $100,000; Nvidia Ready To Run?

The major indexes hit highs Wednesday and bitcoin topped $100,000 late following Fed chief Powell comments. Is Nvidia ready to run?

by: Thomas Matters

Here's Why Dave Inc. (DAVE) is a Great Momentum Stock to Buy

by: Thomas Matters

Tony Robbins: These 3 Investments Can Make You Rich

Investing is a key component of building wealth, but some investments will pay off much more than others. For You: How To Get a 10% Return on Investment (ROI): 10 Proven Ways Learn More:

by: Thomas Matters

CMC Invest launches a flexible Isa - here's how it compares to rivals as it becomes the latest platform to offer tax-free account

by: MSN

Here are the top 10 ASX 200 shares today

The ASX was back to fine form this Thursday... The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

by: Thomas Matters

News Highlights: Top Company News of the Day - Thursday at 1 AM ET

by: Thomas Matters

Best mid cap mutual funds to invest in December 2024

Mid cap mutual funds invest in mid cap stocks or in stocks of medium-sized companies. As per Sebi norms, mid cap schemes are mandated to invest in companies that are between 101 and 250 in the market capitalisation.

by: Thomas Matters

Top Australian financial stocks to buy now

Financias for financial freedom. The post Top Australian financial stocks to buy now appeared first on The Motley Fool Australia.

Why Janux Therapeutics Crushed the Market Today

News of an analyst's price-target hike plus a new round of capital-raising were the sparks that ignited Janux Therapeutics ( JANX 11.65%) stock on Wednesday. The clinical-stage biotech's share price ended the day nearly 12% higher, and this was on a very good day for the exchange with the S&P 500 rising by 0.6%.
Janux Therapeutics (NASDAQ: JANX) experienced a significant surge in its stock price on December 4, 2024, after the company announced positive interim data from its ongoing Phase 1 clinical trial for JANX007, a novel T-cell engager aimed at treating prostate cancer. The trial results indicated a favorable safety profile and promising early signs of efficacy, with several patients showing reductions in PSA levels and tumor size. This news led to a 45% increase in Janux Therapeutics' stock value, far outpacing the broader market's performance. The positive data has heightened investor confidence in the company's pipeline, particularly in its ability to develop effective cancer treatments, thereby driving the stock's impressive performance for the day.

Read the Full The Motley Fool Article at:
https://www.fool.com/investing/2024/12/04/why-janux-therapeutics-crushed-the-market-today/

Like: 👍